CXCR2 and neoplasm: Furthermore, blocking CXCR2 may have deleterious effects on tumor-associated neutrophils and the effects of such therapies in relation to the relative amount of anti-tumor N1 to pro-tumor N2 TANs in the TME necessitates further study.